IL161320A0 - Quinoline derivatives, synthesis method, and medicines containing said derivatives - Google Patents

Quinoline derivatives, synthesis method, and medicines containing said derivatives

Info

Publication number
IL161320A0
IL161320A0 IL16132002A IL16132002A IL161320A0 IL 161320 A0 IL161320 A0 IL 161320A0 IL 16132002 A IL16132002 A IL 16132002A IL 16132002 A IL16132002 A IL 16132002A IL 161320 A0 IL161320 A0 IL 161320A0
Authority
IL
Israel
Prior art keywords
sub
derivatives
synthesis method
coor
cooh
Prior art date
Application number
IL16132002A
Other languages
English (en)
Original Assignee
Bioalliance Pharma
Inst Nat Sante Et Dela Rech Me
Centre Nat Rech Scient
Roussy Inst Gustave
Univ Paris Sud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioalliance Pharma, Inst Nat Sante Et Dela Rech Me, Centre Nat Rech Scient, Roussy Inst Gustave, Univ Paris Sud filed Critical Bioalliance Pharma
Publication of IL161320A0 publication Critical patent/IL161320A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL16132002A 2001-10-12 2002-10-14 Quinoline derivatives, synthesis method, and medicines containing said derivatives IL161320A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113209A FR2830863B1 (fr) 2001-10-12 2001-10-12 Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives
PCT/FR2002/003512 WO2003031413A1 (fr) 2001-10-12 2002-10-14 Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives

Publications (1)

Publication Number Publication Date
IL161320A0 true IL161320A0 (en) 2004-09-27

Family

ID=8868255

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16132002A IL161320A0 (en) 2001-10-12 2002-10-14 Quinoline derivatives, synthesis method, and medicines containing said derivatives
IL161320A IL161320A (en) 2001-10-12 2004-04-07 Quinoline derivatives, a method for their synthesis, pharmaceutical compositiions comprising the same and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161320A IL161320A (en) 2001-10-12 2004-04-07 Quinoline derivatives, a method for their synthesis, pharmaceutical compositiions comprising the same and uses thereof

Country Status (10)

Country Link
US (2) US7064133B2 (enExample)
EP (1) EP1461319B1 (enExample)
JP (1) JP2005508350A (enExample)
AT (1) ATE430134T1 (enExample)
DE (1) DE60232186D1 (enExample)
DK (1) DK1461319T3 (enExample)
ES (1) ES2326115T3 (enExample)
FR (1) FR2830863B1 (enExample)
IL (2) IL161320A0 (enExample)
WO (1) WO2003031413A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2830863B1 (fr) * 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives
FR2839646B1 (fr) 2002-05-17 2008-04-11 Bioalliance Pharma Utilisation de derives de quinoleine a effet anti-integrase et ses applications
US7132432B2 (en) * 2003-06-05 2006-11-07 Bristol-Myers Squibb Company Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
TW200510425A (en) 2003-08-13 2005-03-16 Japan Tobacco Inc Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
WO2005028478A1 (en) 2003-09-19 2005-03-31 Gilead Sciences, Inc. Aza-quinolinol phosphonate integrase inhibitor compounds
WO2006129134A1 (en) * 2005-06-01 2006-12-07 Bioalliance Pharma Synergic combinations comprising a styrylquinoline compound and other hiv infection therapeutic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761687B1 (fr) * 1997-04-08 2000-09-15 Centre Nat Rech Scient Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
FR2830863B1 (fr) * 2001-10-12 2004-01-30 Bioalliance Pharma Derives de quinoleine, procede de synthese, et medicaments renfermant ces derives

Also Published As

Publication number Publication date
JP2005508350A (ja) 2005-03-31
US20060148849A1 (en) 2006-07-06
EP1461319A1 (fr) 2004-09-29
FR2830863A1 (fr) 2003-04-18
ATE430134T1 (de) 2009-05-15
US7064133B2 (en) 2006-06-20
IL161320A (en) 2009-09-01
DK1461319T3 (da) 2009-08-03
FR2830863B1 (fr) 2004-01-30
WO2003031413A1 (fr) 2003-04-17
EP1461319B1 (fr) 2009-04-29
US20040259911A1 (en) 2004-12-23
ES2326115T3 (es) 2009-10-01
DE60232186D1 (de) 2009-06-10

Similar Documents

Publication Publication Date Title
DK1104760T3 (da) Sulfamoylheteroarylpyrazolforbindelser som anti-inflammatoriske/analgetiske midler
DE69925141D1 (de) Chinazolin derivate
ES2137169T3 (es) Nuevos derivados de tiazolilbenzofurano, procedimientos para su preparacion y composicion farmaceutica que los contiene.
MXPA04005350A (es) Compuesto de dibencilamina, y uso medicinal del mismo.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
PT98358A (pt) Processo para a preparacao de novos compostos pirazolopiridinicos
DK1104759T3 (da) Heteroarylphenylpyrazolforbindelser som antiinflammatoriske/analgetiske midler
DE69309435D1 (de) Restenosehemmer nach perkutaner koronarer arterioplastie
EA200100994A1 (ru) 1-АМИНОТРИАЗОЛО[4,3-а]ХИНАЗОЛИН-5-ОНЫ И/ИЛИ -5-ТИОНЫ, ИНГИБИРУЮЩИЕ ФОСФОДИЭСТЕРАЗУ-IV
HUP0100184A2 (hu) Szubsztituált 2-(benzil-amino)-2-fenil-acetamid-vegyületek és ezeket tartalmazó gyógyszerkészítmények
IL161320A0 (en) Quinoline derivatives, synthesis method, and medicines containing said derivatives
ATE81655T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
TNSN97092A1 (ar) مثبطات انزيم بروتيني فلزي وتركيبات صيدلانية تحتوي على تلك المثبتطات واستخدامها الصيدلاني وطرق ومركبات وسيطة مفيدة لتحضير التركيبات المذكورة.
ES2189080T3 (es) Derivados de creatina para el asma.
AU7529487A (en) Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them
PT1209166E (pt) Novos derivados de a-500359
ITMI922742A1 (it) Composti ad attivita' terapeutica utili per il trattamento di malattie connesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
BR9813241A (pt) Derivados de guanidina substituìdos
PT1430034E (pt) Derivados de alquilaminopiridazinona substituida processo para sua preparacao e composicoes farmaceuticas que os contem
EA200200379A3 (ru) Новые соединения пиримидин-4-она, способ их получения и содержащие их фармацевтические композиции
ATE497497T1 (de) 1,2,4-triazolderivat, verfahren zu dessenherstellung, und dieses enthaltende pharmazeutische zusammensetzung
PL338132A1 (en) Derivatives of polyhydroxylbutylpyrazine, method of obtaining and drugs containing them
BR0014319A (pt) Derivados de pirimidina, processo para preparação dos derivados e drogas contendo o mesmos como o ingrediente ativo